“…On the other hand, the protection afforded by practolol and the (-)-enantiomer of sotalol (MJ1999)-drugs which lack membranestabilizing properties (Singh & Vaughan Williams, 1970)-suggests that /3-adrenoceptor blockade alone can be responsible for this effect; the (+Ienantiomer of sotalol, which is weak in this respect (Patil, 1968) proved inactive against ouabain. Similarly, the (-)-enantiomer of INPEA, which is also weak in membrane-stabilizing properties (Singh & Vaughan Williams, 1971), but is responsible for all the /3-adrenoceptor blocking activity of this compound (Patil, 1968;Almirante & Murmann, 1966) showed protective activity against ouabain toxicity, though of a low order, such that activity could not be established for (&)-INPEA below toxic doses. cr-Methyl INPEA, which is only very weakly active on cardiac P-adrenoceptors (Somani, 1969), also showed only slight activity in this situation.…”